Document is current
Any future updates will be listed below
-
Authors
Lisai-Goldstein, Yaara
Focht, Gili
Orlanski-Meyer, Esther
Yogev, Dotan
Lev-Tzion, Raffi
Ledder, Oren
Assa, Amit
Navas-López, Victor Manuel
Baldassano, Robert N.
Otley, Anthony
Shouval, Dror S.
Griffiths, Anne M.
Turner, Dan
Atia, Ohad
-
Funding
Funding for this research was provided by:
AbbVie Canada (IMM-11-0077)
- License Information
-
More Information
Article History
Received: 30 September 2024
Accepted: 4 November 2024
First Online: 27 November 2024
Declarations
:
: Competing interest declaration: YLG – None GF – None EOM – None DY – None RLT – None OL – None AA – None VMNL – None RNB – None AO – None DS – None AMG – None DT – For the past three years, has received consultation fees, research grants, royalties, or honorariaum from Janssen, Pfizer, Hospital for Sick Children (Canada), Ferring, AbbVie, Takeda, Atlantic Health System, Shire, Celgene, Lilly, Roche, ThermoFisher, BMS OA – none.
: This study was approved by the local ethics committee of the participating medical centers and all participants signed informed consent.
